Business Wire
14 Oct 2026, 05:00 UTC · 4h ago
Galderma Signs Agreement to Acquire ZO Skin Health, Strengthening Its Physician-Dispensed Skincare Offering
Impact · against what's priced in
Galderma's acquisition of ZO Skin Health provides a catalyst for top-line growth and EPS accretion starting in FY2027 by expanding its physician-dispensed skincare footprint. The move strengthens GALD's portfolio position through the integration of a clinically-backed reference brand.
- GALD+0.60
No priced-in read yet





